ClinicalTrials.gg
CompletedNCT07838376Updated Oct 13, 2026

Preceding Pain and Development of Additional Pain in Patients With CRPS

An observational study in Complex Regional Pain Syndrome (CRPS), sponsored by Walton Centre NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Walton Centre NHS Foundation Trust · Observational

Updated Oct 13, 2026Now CompletedStudy completion moved+1 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
705
Ages
18 Years and older
Sex
All
01

Study summary

Complex regional pain syndrome (CRPS) is a very painful condition that can have a huge impact on people's lives. Despite progress having been made in understanding what CRPS is and how it affects people, there are still many questions that remain unanswered. Research plays an important role in helping healthcare professionals understand illness and develop new treatments. The purpose of this study is to contribute to understanding of CRPS, specifically by seeing whether there are links between CRPS and other chronic pains. A study done at the Walton Centre in the past suggested that there may be some links, which the investigators will re-examine in this study in more detail, as well as asking other important questions which may bring new information to light.

Read the detailed description

This cross-sectional study will use a questionnaire-based method to gather information on pre-existing pain, before CRPS development, at the same site where CRPS then develops, and on additional pain (pre-existing or later developing) from a large cohort of patients with CRPS. This will allow a large amount of data to be collected in a time-efficient manner and enable comparison between different groups, for example, those who developed widespread pain before or after their diagnosis of CRPS. The investigators know from existing research that widespread pain is a relatively common phenomenon in patients with CRPS; on this basis they expect its frequency in the cohort to be such that they may be able to detect statistically significant patterns in its development, for example a different frequency in certain age groups. Thus the questionnaire will feature questions about the patient's CRPS diagnosis and any additional pain they have experienced, including its time course of development and nature. It will also include questions about other symptoms that are more commonly observed in chronic widespread pain than in CRPS, such as cognitive symptoms and sleep disturbance, and which form part of the ACR 2016 criteria for fibromyalgia syndrome diagnosis. Independently, given the unexpected finding of CRPS-preceding pains in the later CRPS-affected limb in a previous Walton Centre study, the investigators will also more systematically evaluate this phenomenon.

02

Conditions studied

  • Complex Regional Pain Syndrome (CRPS)

Keywords

  • CRPS
  • Fibromyalgia
03

In context

Complex Regional Pain Syndromes

206 studies on the registry are indexed under Complex Regional Pain Syndromes; 55 are open to participants now.

This study's enrollment of 705 is above the median of 58 across 44 observational studies indexed under Complex Regional Pain Syndromes.

Browse Complex Regional Pain Syndromes studies →

Lead sponsor

Walton Centre NHS Foundation Trust is the lead sponsor of 17 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

People with CRPS first seen in outpatient clinic by Walton Centre Pain consultants between 2007 and 2023, who had consented to have their data entered into the Walton Centre CRPS database

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed CRPS diagnosis
  • Age 18+ at time of study
  • Seen by Prof. A. Goebel or another Walton Centre Pain Consultant as a new patient between 2007 and 2023.
  • Data previously entered into the Walton Centre Registry.
  • Patients, whose clinic letters who have been analysed for the previous 2014 study, will not be excluded.

Exclusion criteria

Exclusion Criteria:

  • Under the age of 18 at time of survey
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
705 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Frequency and nature of chronic pain preceding CRPS onset, and additional pain development in patients with CRPS

    Bespoke questionnaire tracking preceding pain location and intensity prior to CRPS, initial CRPS location and intensity and impact and pain following CRPS diagnosis. Included EQ-5D-5L questionnaire to track current overall quality of life.

    Time frame: From date recorded by patient of first preceding pain / CRPS diagnosis, to date questionnaire received by patient. Expected time frame from this of 1-20 years based on patient response.

07

Study locations

1 site
  • The Walton Centre NHS Foundation Trust
    Liverpool, Merseyside L109LY, United Kingdom
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Oct 2024 to primary completion in Jun 2025, 8 months.

Completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2026
First posted
Sep 24, 2026
StartActual
Oct 30, 2024
Primary completionActual
Jun 30, 2025
CompletionActual
Oct 5, 2026was Sep 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 13, 2026
Study completion
Sep 30, 2026→Oct 5, 2026 (actual)
Oct 13, 2026
Enrollment
500 (estimated)→705 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Active, not recruiting→Completed
    Study completion Sep 30, 2026→Oct 5, 2026 (now actual)
    Enrollment 500 (estimated)→705 (actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07838376
Lead sponsor
Walton Centre NHS Foundation Trust
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
Oct 30, 2024
Primary completion
Jun 30, 2025
Completion
Oct 5, 2026
Last update
Oct 13, 2026

Study contacts

Andreas Goebel
principal investigator · Walton Centre NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion